Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Tapering in Chronic Pain
NCT03365817Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Feb 2009
- Primary completion
- Dec 2014
01
Overview
Phase 3, randomised, open-label trial in chronic pain and opioid use disorder (OUD), sponsored by Rigshospitalet. Primary endpoint: Cognitive function - sustained attention at 6 months. Started Feb 2009; status: completed.
02
Conditions
chronic painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03365817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03365817.